RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

Regulatory Focus™ > News Articles > Perspective: Generic Drug approvals in the US Prior to the Hatch-Waxman Act

Perspective: Generic Drug approvals in the US Prior to the Hatch-Waxman Act

Posted 01 September 2008 | By

It is a common misconception that the Hatch-Waxman Act of 19841 created the generic drug approval process in the US. A recent article claimed there were few generic drugs approved in the US before that act was passed.2

Regulatory Focus newsletters

All the biggest regulatory news and happenings.

Subscribe

Regulatory Focus™ is doing essential, non-biased journalism during this unprecedented time. We appreciate your support as we bring you the news and intelligence you need to make an impact on global healthcare.

Regulatory Focus™ provides the intelligence you need to impact global healthcare during this crisis. Thank you for your support.